EX-99.1 2 ex_1001659.htm EXHIBIT 99.1 ex_1001659.htm

Exhibit 99.1

logo01.jpg

FOR IMMEDIATE RELEASE

 

SUPERIOR GROUP OF COMPANIES REPORTS THIRD QUARTER 2026 RESULTS

 

• Total net sales of $146.0 million, up 5% over prior year third quarter
• Net income of $2.6 million versus $2.7 million in prior year third quarter
• Adjusted EBITDA of $6.7 million versus $7.5 million in prior year third quarter
• Tightens full-year Outlook 

 

ST. PETERSBURG, Fla., November 9, 2026 – Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its third quarter 2026 results.

 

“We drove solid overall top line growth from continued momentum in our Branded Products and Contact Centers segments,” said Michael Benstock, Chief Executive Officer. “New leadership in Healthcare Apparel continues to execute toward a more focused product strategy to improve margins and reduce working capital requirements in the quarters ahead. On a consolidated basis, we were able to hold EPS essentially flat versus the prior year quarter despite incremental charges associated with our strategic shift in Healthcare Apparel. We look forward to finishing the year with growth in both sales and earnings compared to 2025, and with a solid balance sheet that provides the foundation for continued strategic investment such as our recent acquisition of Select VoiceCom and the return of capital to shareholders.”

 

Third Quarter Results

 

For the third quarter ended September 30, 2026, net sales were $146.0 million, up 5% from third quarter 2025 net sales of $138.5 million. Net income was $2.6 million or $0.17 per diluted share compared to net income of $2.7 million or $0.18 per diluted share for the third quarter of 2025.

 

2026 Full-Year Outlook

 

The Company tightened its full-year 2026 net sales forecast to a range of $578.0 million to $585.0 million, from its previous range of $572.0 million to $585.0 million, up from 2025 net sales of $566.2 million. It also tightened its full-year adjusted earnings per diluted share forecast to a range of $0.60 to $0.66, from its previous range of $0.54 to $0.66, up from $0.46 in 2025 and representing 43% growth at the high end.

 

1


 

Webcast and Conference Call

 

The Company will host a webcast and conference call at 8:00am Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for international dialers. The Canadian toll-free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through November 23, 2026. To access the replay, dial 1-855-669-9658 in the United States or Canada, or 1-412-317-0088 from international locations. Please reference conference number 8522694 for replay access.

 

Disclosure Regarding Forward-Looking Statements

 

Certain matters discussed in this press release are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “project,” “potential,” or “plan” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release include 2026 guidance of net sales and earnings per diluted share and may also include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

 

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; the impact of global conflicts, such as the Russia-Ukraine War and the joint U.S.-Israeli War with Iran in 2026, oil and natural gas prices, uncertainties related to tariffs, duties, trade wars and related matters, supply disruptions, inflationary environments (including with respect to shipping costs and the cost of finished goods and raw materials), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (“U.S.” or “United States”) in which the Company’s customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the Company's ability to maintain effective internal control over financial reporting; and other factors described in the Company’s filings with the Securities and Exchange Commission ("SEC"), including those risks described in Item 1A of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 entitled "Risk Factors" and the Quarterly Report on Form 10-Q for the quarter ended September 30, 2026. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

 

About Superior Group of Companies, Inc. (SGC):

 

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

 

Investor Relations Contact: 
[email protected]

 

2


  

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except shares and per share data)

 

​

​

Three Months Ended September

​

​

Nine Months Ended September 30,

​

​

​

2026

​

​

2025

​

​

2026

​

​

2025

​

Net sales

​

$

145,994

​

​

$

138,467

​

​

$

434,708

​

​

$

419,609

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Costs and expenses:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cost of goods sold

​

​

90,168

​

​

​

85,389

​

​

​

270,429

​

​

​

260,764

​

Selling and administrative expenses

​

​

51,866

​

​

​

48,513

​

​

​

153,561

​

​

​

150,855

​

Interest expense, net

​

​

809

​

​

​

1,378

​

​

​

2,702

​

​

​

3,873

​

Trade name impairment charge

​

​

-

​

​

​

-

​

​

​

2,600

​

​

​

-

​

​

​

​

142,843

​

​

​

135,280

​

​

​

429,292

​

​

​

415,492

​

Income before income tax expense

​

​

3,151

​

​

​

3,187

​

​

​

5,416

​

​

​

4,117

​

Income tax expense

​

​

580

​

​

​

443

​

​

​

790

​

​

​

580

​

Net income

​

$

2,571

​

​

$

2,744

​

​

$

4,626

​

​

$

3,537

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Net income per share:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic

​

$

0.17

​

​

$

0.19

​

​

$

0.32

​

​

$

0.24

​

Diluted

​

$

0.17

​

​

$

0.18

​

​

$

0.31

​

​

$

0.23

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average shares outstanding during the period:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Basic

​

​

14,787,455

​

​

​

14,738,863

​

​

​

14,637,206

​

​

​

15,050,834

​

Diluted

​

​

15,247,892

​

​

​

15,119,050

​

​

​

15,024,519

​

​

​

15,422,144

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Cash dividends per common share

​

$

0.14

​

​

$

0.14

​

​

$

0.42

​

​

$

0.42

​

     

3


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except shares and par value data)

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$27,924

 

 

$23,691

 

Accounts receivable, net

 

 

96,273

 

 

 

104,336

 

Inventories

 

 

87,936

 

 

 

97,474

 

Contract assets

 

 

52,860

 

 

 

48,903

 

Prepaid expenses and other current assets

 

 

16,741

 

 

 

13,259

 

Total current assets

 

 

281,734

 

 

 

287,663

 

Property, plant and equipment, net

 

 

34,250

 

 

 

37,352

 

Operating lease right-of-use assets

 

 

11,258

 

 

 

12,620

 

Deferred tax asset

 

 

14,954

 

 

 

15,003

 

Intangible assets, net

 

 

42,051

 

 

 

47,254

 

Goodwill

 

 

2,583

 

 

 

2,583

 

Other assets

 

 

21,009

 

 

 

19,369

 

Total assets

 

$407,839

 

 

$421,844

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable

 

$51,325

 

 

$48,343

 

Other current liabilities

 

 

52,222

 

 

 

53,041

 

Current portion of long-term debt

 

 

3,750

 

 

 

6,563

 

Current portion of acquisition-related contingent liabilities

 

 

682

 

 

 

-

 

Total current liabilities

 

 

107,979

 

 

 

107,947

 

Long-term debt

 

 

74,287

 

 

 

87,093

 

Long-term pension liability

 

 

15,233

 

 

 

15,010

 

Long-term acquisition-related contingent liabilities

 

 

455

 

 

 

826

 

Long-term operating lease liabilities

 

 

6,630

 

 

 

7,939

 

Other long-term liabilities

 

 

10,217

 

 

 

10,211

 

Total liabilities

 

 

214,801

 

 

 

229,026

 

Shareholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value - authorized 300,000 shares (none issued)

 

 

-

 

 

 

-

 

Common stock, $0.001 par value - authorized 50,000,000 shares, issued and outstanding 15,894,450 and 15,730,615 shares, respectively

 

 

16

 

 

 

16

 

Additional paid-in capital

 

 

86,088

 

 

 

84,628

 

Retained earnings

 

 

110,169

 

 

 

112,871

 

Accumulated other comprehensive loss, net of tax

 

 

(3,235)

 

 

(4,697)

Total shareholders’ equity

 

 

193,038

 

 

 

192,818

 

Total liabilities and shareholders’ equity

 

$407,839

 

 

$421,844

 

 

4


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

 

Net income

 

$4,626

 

 

$3,537

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

8,489

 

 

 

9,157

 

Inventory write-downs

 

 

9,498

 

 

 

1,793

 

Credit loss expense

 

 

3,165

 

 

 

2,347

 

Share-based compensation expense

 

 

2,523

 

 

 

3,916

 

Trade name impairment charge

 

 

2,600

 

 

 

-

 

Change in fair value of acquisition-related contingent liabilities

 

 

311

 

 

 

659

 

Non-cash operating lease expense

 

 

3,116

 

 

 

2,843

 

Other, net

 

 

183

 

 

 

244

 

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Accounts receivable

 

 

5,338

 

 

 

(3,710)

Contract assets

 

 

(3,920)

 

 

3,326

 

Inventories

 

 

91

 

 

 

(10,535)

Prepaid expenses and other current assets

 

 

(2,963)

 

 

(423

)

Other assets

 

 

(1,778)

 

 

(1,692)

Accounts payable and other current liabilities

 

 

(1,432)

 

 

(10,636)

Payment of acquisition-related contingent liabilities

 

 

-

 

 

 

(791

)

Other long-term liabilities

 

 

832

 

 

 

1,235

 

Net cash provided by operating activities

 

 

30,679

 

 

 

1,270

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Additions to property, plant and equipment

 

 

(2,675)

 

 

(3,407)

Net cash used in investing activities

 

 

(2,675)

 

 

(3,407)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Borrowings under revolving lines of credit

 

 

33,545

 

 

 

76,000

 

Payments under revolving lines of credit

 

 

(63,545)

 

 

(58,000)

Borrowings under term loan

 

 

24,375

 

 

 

-

 

Payments of term loan

 

 

(9,375)

 

 

(4,218)

Debt issuance costs

 

 

(821)

 

 

-

 

Payments of cash dividends

 

 

(6,575)

 

 

(6,713)

Payment of acquisition-related contingent liabilities

 

 

-

 

 

 

(226

)

Shares withheld for taxes net of proceeds received on exercise of stock options

 

 

(351)

 

 

90

 

Common shares repurchased and retired

 

 

(1,465)

 

 

(7,928)

Net cash used in financing activities

 

 

(24,212)

 

 

(995

)

 

 

 

 

 

 

 

 

 

Effect of currency exchange rates on cash

 

 

441

 

 

 

1,017

 

Net increases (decreases) in cash and cash equivalents

 

 

4,233

 

 

 

(2,115

)

Cash and cash equivalents balance, beginning of period

 

 

23,691

 

 

 

18,766

 

Cash and cash equivalents balance, end of period

 

$27,924

 

 

$16,651

 

 

5


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

ADJUSTED NET INCOME & NON-GAAP RECONCILIATION

(Unaudited)

(In thousands)

 

​

​

Three Months Ended September 30,

​

​

Nine Months Ended September 30,

​

​

​

2026

​

​

2025

​

​

2026

​

​

2025

​

Net income

​

$

2,571

​

​

$

2,744

​

​

$

4,626

​

​

$

3,537

​

Add backs:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Trade name impairment charge

​

​

-

​

​

​

-

​

​

​

2,600

​

​

​

-

​

Tax impact of adjustments(1)

​

​

-

​

​

​

-

​

​

​

(640

)

​

​

-

​

Adjusted net income(2)

​

$

2,571

​

​

$

2,744

​

​

$

6,586

​

​

$

3,537

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Diluted net income per share

​

$

0.17

​

​

$

0.18

​

​

$

0.31

​

​

$

0.23

​

Add back items, after-tax, per diluted share

​

​

-

​

​

​

-

​

​

​

0.13

​

​

​

-

​

Diluted adjusted net income per share(2)

​

$

0.17

​

​

$

0.18

​

​

$

0.44

​

​

$

0.23

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted average shares outstanding during the period:

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Diluted, as reported and adjusted

​

​

15,247,892

​

​

​

15,119,050

​

​

​

15,024,519

​

​

​

15,422,144

​

 

(1) The tax impact of adjustments includes the tax effect of each separate adjustment based on the statutory tax rate for the jurisdiction(s) in which the adjustment was taxable or deductible, and the tax effect of items that relate to tax specific financial transactions.

(2) Adjusted net income and diluted adjusted net income per share, which are non-GAAP measures, are defined as net income (loss) and net income (loss) per share, excluding the impacts of impairment and pension plan termination charges. Management believes adjusted net income (loss) and diluted adjusted net income (loss) per share provides useful information to investors because it allows management, investors and others to evaluate and compare our operating results from period to period by removing the impact of impairment and pension plan termination charges that are not reflective of our core business. Adjusted net income and Diluted adjusted net income per share should not be considered in isolation or as an alternative to net income or net income per share or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted net income and Diluted adjusted net income per share are significant components in understanding and assessing the Company’s net income. The Company’s Adjusted net income and Diluted adjusted net income per share may not be comparable to a similarly titled measure of another company because other companies may not calculate Adjusted net income and Diluted adjusted net income per share in the same manner.

 

 

6


 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS & NON-GAAP RECONCILIATIONS

(Unaudited)

(In thousands)

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Total

 

For the Three Months Ended September 30, 2026:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$92,111

 

 

$30,553

 

 

$24,224

 

 

$(894)

 

$145,994

 

Cost of goods sold

 

 

58,602

 

 

 

20,575

 

 

 

11,398

 

 

 

(407)

 

 

90,168

 

Gross margin

 

 

33,509

 

 

 

9,978

 

 

 

12,826

 

 

 

(487)

 

 

55,826

 

Less: Selling and administrative expenses

 

 

24,961

 

 

 

11,303

 

 

 

10,496

 

 

 

(487)

 

 

46,273

 

Less: Trade name impairment charge

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Add backs:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade name impairment charge

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Segment depreciation and amortization

 

 

1,295

 

 

 

824

 

 

 

567

 

 

 

-

 

 

 

2,686

 

Segment Adjusted EBITDA(4)

 

$9,843

 

 

$(501)

 

$2,897

 

 

$-

 

 

$12,239

 

Less corporate selling and administrative expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,593

 

Add back corporate depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61

 

Adjusted EBITDA(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$6,707

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Total

 

For the Three Months Ended September 30, 2025:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$85,095

 

 

$31,520

 

 

$22,664

 

 

$(812)

 

$138,467

 

Cost of goods sold

 

 

55,466

 

 

 

19,394

 

 

 

10,669

 

 

 

(140)

 

 

85,389

 

Gross margin

 

 

29,629

 

 

 

12,126

 

 

 

11,995

 

 

 

(672)

 

 

53,078

 

Less: Selling and administrative expenses

 

 

23,501

 

 

 

9,779

 

 

 

10,283

 

 

 

(672)

 

 

42,891

 

Add backs:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment depreciation and amortization

 

 

1,396

 

 

 

832

 

 

 

661

 

 

 

-

 

 

 

2,889

 

Segment Adjusted EBITDA(4)

 

$7,524

 

 

$3,179

 

 

$2,373

 

 

$-

 

 

$13,076

 

Less corporate selling and administrative expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5,622

 

Add back corporate depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

86

 

Adjusted EBITDA(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$7,540

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7


 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Total

 

For the Nine Months Ended September 30, 2026:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$281,370

 

 

$86,385

 

 

$69,571

 

 

$(2,618)

 

$434,708

 

Cost of goods sold

 

 

181,002

 

 

 

57,259

 

 

 

33,381

 

 

 

(1,213)

 

 

270,429

 

Gross margin

 

 

100,368

 

 

 

29,126

 

 

 

36,190

 

 

 

(1,405)

 

 

164,279

 

Less: Selling and administrative expenses

 

 

75,708

 

 

 

32,027

 

 

 

30,413

 

 

 

(1,405)

 

 

136,743

 

Less: Trade name impairment charge

 

 

-

 

 

 

2,600

 

 

 

-

 

 

 

-

 

 

 

2,600

 

Add backs:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trade name impairment charge

 

 

-

 

 

 

2,600

 

 

 

-

 

 

 

-

 

 

 

2,600

 

Segment depreciation and amortization

 

 

4,013

 

 

 

2,466

 

 

 

1,804

 

 

 

-

 

 

 

8,283

 

Segment Adjusted EBITDA(4)

 

$28,673

 

 

$(435

)

 

$7,581

 

 

$-

 

 

$35,819

 

Less corporate selling and administrative expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

16,818

 

Add back corporate depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

206

 

Adjusted EBITDA(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$19,207

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Branded Products

 

 

Healthcare Apparel

 

 

Contact Centers

 

 

Intersegment Eliminations

 

 

Total

 

For the Nine Months Ended September 30, 2025:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net sales

 

$264,216

 

 

$87,036

 

 

$70,866

 

 

$(2,509)

 

$419,609

 

Cost of goods sold

 

 

173,884

 

 

 

54,761

 

 

 

33,277

 

 

 

(1,158)

 

 

260,764

 

Gross margin

 

 

90,332

 

 

 

32,275

 

 

 

37,589

 

 

 

(1,351)

 

 

158,845

 

Less: Selling and administrative expenses

 

 

72,353

 

 

 

29,383

 

 

 

32,816

 

 

 

(1,351)

 

 

133,201

 

Add backs:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment depreciation and amortization

 

 

4,271

 

 

 

2,598

 

 

 

2,022

 

 

 

-

 

 

 

8,891

 

Segment Adjusted EBITDA(4)

 

$22,250

 

 

$5,490

 

 

$6,795

 

 

$-

 

 

$34,535

 

Less corporate selling and administrative expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,654

 

Add back corporate depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

266

 

Adjusted EBITDA(3)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$17,147

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles income before income tax expense to Total Segment Adjusted EBITDA (in thousands):

 

​

​

Three Months Ended September 30,

​

​

Nine Months Ended September 30,

​

​

​

2026

​

​

2025

​

​

2026

​

​

2025

​

Income before income tax expense

​

$

3,151

​

​

$

3,187

​

​

$

5,416

​

​

$

4,117

​

Interest expense, net

​

​

809

​

​

​

1,378

​

​

​

2,702

​

​

​

3,873

​

Corporate selling and administrative expenses

​

​

5,593

​

​

​

5,622

​

​

​

16,818

​

​

​

17,654

​

Segment depreciation and amortization

​

​

2,686

​

​

​

2,889

​

​

​

8,283

​

​

​

8,891

​

Trade name impairment charge

​

​

-

​

​

​

-

​

​

​

2,600

​

​

​

-

​

Total Segment Adjusted EBITDA

​

$

12,239

​

​

$

13,076

​

​

$

35,819

​

​

$

34,535

​

 

8


The following table reconciles net income to Adjusted EBITDA (in thousands):

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Net income

 

$

2,571

 

 

$

2,744

 

 

$

4,626

 

 

$

3,537

 

Interest expense, net

 

 

809

 

 

 

1,378

 

 

 

2,702

 

 

 

3,873

 

Income tax expense

 

 

580

 

 

 

443

 

 

 

790

 

 

 

580

 

Segment depreciation and amortization

 

 

2,686

 

 

 

2,889

 

 

 

8,283

 

 

 

8,891

 

Corporate depreciation and amortization

 

 

61

 

 

 

86

 

 

 

206

 

 

 

266

 

Trade name impairment charge

 

 

-

 

 

 

-

 

 

 

2,600

 

 

 

-

 

Adjusted EBITDA(3)

 

$

6,707

 

 

$

7,540

 

 

$

19,207

 

 

$

17,147

 

Adjusted EBITDA margin(3)

 

 

4.6

%

 

 

5.4

%

 

 

4.4

%

 

 

4.1

%

 

(3) Adjusted EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense, impairments and depreciation and amortization expense. Adjusted EBITDA margin is defined as Adjusted EBITDA divided by net sales. The Company believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences, (iii) asset base (depreciation and amortization) and (iv) impairments. The Company uses Adjusted EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used Adjusted EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. Adjusted EBITDA is not a measure of financial performance under GAAP.  Adjusted EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate Adjusted EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s Adjusted EBITDA may not be comparable to a similarly titled measure of another company because other companies may not calculate Adjusted EBITDA in the same manner.

(4) Segment Adjusted EBITDA, as reported above for each segment, is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment Adjusted EBITDA include: interest expense, net, impairments and depreciation and amortization expense. Total Segment Adjusted EBITDA is a non-GAAP financial measure and is reconciled to its most closely comparable GAAP metric of income before income tax expense in the table above. 

 

9